- Report
- November 2023
- 420 Pages
Global
From €4217EUR$4,450USD£3,559GBP
- Report
- November 2023
- 320 Pages
Global
From €4217EUR$4,450USD£3,559GBP
- Report
- January 2023
- 154 Pages
From €3269EUR$3,450USD£2,759GBP
- Report
- July 2023
- 140 Pages
Global
From €4690EUR$4,949USD£3,958GBP
- Report
- January 2025
- 82 Pages
Vietnam
From €3317EUR$3,500USD£2,799GBP
- Report
- October 2024
- 87 Pages
India
From €3317EUR$3,500USD£2,799GBP
- Report
- August 2022
- 120 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- March 2024
- 200 Pages
Global
From €3933EUR$4,150USD£3,319GBP
- Report
- May 2021
- 120 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- April 2023
- 111 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- August 2022
- 120 Pages
Global
From €4501EUR$4,750USD£3,799GBP
- Report
- October 2023
- 84 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- December 2022
- 115 Pages
Global
From €4264EUR$4,500USD£3,599GBP
- Report
- October 2023
- 185 Pages
Global
€4544EUR$4,795USD£3,835GBP
- Drug Pipelines
- June 2020
- 48 Pages
Global
From €1895EUR$2,000USD£1,599GBP
- Report
- December 2023
- 255 Pages
Global
From €2369EUR$2,500USD£1,999GBP
- Report
- December 2023
- 80 Pages
France
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Germany
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
India
From €1421EUR$1,500USD£1,200GBP
- Report
- December 2023
- 80 Pages
Saudi Arabia
From €1421EUR$1,500USD£1,200GBP

The antimalarial market is a subset of the infectious diseases drugs market, which focuses on the treatment and prevention of malaria. Antimalarial drugs are used to treat and prevent the spread of the Plasmodium parasite, which is responsible for the disease. These drugs are typically administered orally, intravenously, or intramuscularly, depending on the severity of the infection. Common antimalarial drugs include chloroquine, artemisinin, and mefloquine.
In addition to antimalarial drugs, the market also includes insecticides, insect repellents, and other preventive measures. These products are used to reduce the risk of infection by controlling the mosquito population, which is the primary vector for the Plasmodium parasite.
Notable companies in the antimalarial market include GlaxoSmithKline, Sanofi, Novartis, and Merck. These companies produce a variety of antimalarial drugs, insecticides, and other preventive measures. Show Less Read more